Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Diphtheria toxoid, Tetanus toxoid, and Acellular pertussis antigens (DTaP (for children), Tdap (for adolescents/adults)[9][7])
- Target
- DTaP (for children), Tdap (for adolescents/adults)[9][7]
- Molecular classification
- Other
01
Overview
Diphtheria toxoid, tetanus toxoid, and acellular pertussis antigens are the active components in combination vaccines (DTaP, Tdap) to prevent diphtheria (caused by *Corynebacterium diphtheriae*), tetanus (caused by *Clostridium tetani*), and pertussis (caused by *Bordetella pertussis*). The diphtheria and tetanus components are inactivated, detoxified toxins (“toxoids”), while the pertussis component consists of purified, important bacterial antigens (such as pertussis toxin, filamentous hemagglutinin, pertactin, and fimbriae) rather than whole bacterial cells. These antigens are not drug targets but are designed to elicit adaptive immunity, mostly antibody-mediated, to neutralize toxins and facilitate clearance of infection if exposure occurs[9][5][7].
- Other names
- DTaP vaccine antigensTdap vaccine antigensDTP vaccine antigens
02
Mechanism of action
Induction of protective immunity via adaptive immune response to toxins and/or bacterial virulence factors
03
Biological functions
Immune response induction
04
Disease associations
Infection (specifically, protection from diphtheria, tetanus, and pertussis)
05
Safety considerations
Allergic reactionsInjection site reactionsFeverRarely anaphylaxis or neurologic events
06
Interacting drugs
Not applicable
07
Biomarkers
Antibody titers to diphtheria toxoidAntibody titers to tetanus toxoidAntibody titers to pertussis antigens (such as pertussis toxin, filamentous hemagglutinin, pertactin, fimbriae antibodies)
Beyond the preview
Go deeper on Diphtheria toxoid, Tetanus toxoid, and Acellular pertussis antigens (DTaP (for children), Tdap (for adolescents/adults)[9][7]).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Diphtheria toxoid, Tetanus toxoid, and Acellular pertussis antigens (DTaP (for children), Tdap (for adolescents/adults)[9][7]).